Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.
Kreyenberg
H
H
Eckert
C
C
Yarkin
Y
Y
Reising
M
M
Willasch
A
A
Handgretinger
R
R
Kremens
B
B
von Stackelberg
A
A
Henze
G
G
Klingebiel
T
T
Bader
P
P
D000293:Adolescent; D000328:Adult; D014408:Biomarkers, Tumor; D002648:Child; D002675:Child, Preschool; D015321:Gene Rearrangement; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics*; D007223:Infant; D018365:Neoplasm, Residual / Q000175:diagnosis*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D033581:Stem Cell Transplantation
D014408:Biomarkers, Tumor; D007136:Immunoglobulins; D011948:Receptors, Antigen, T-Cell